Paragon (FNA) | Stock Overview & Key Data
Paragon Performance Comparison
Stock Range
Today's Range
Low: $13.06
High: $13.11
on June 20, 2025
52 Week Range
Low: $4.65
High: $13.13
on October 29, 2024
on January 29, 2025
All-Time High: $25.41 on November 8, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.1B
EPS
-0.66
P/E Ratio (TTM)
N/A
Forward P/E
-27.85
P/B Ratio
8.41
PEG Ratio
-27.85
Div. Yield
N/A
ROE
-36.39%
Beta
1.473
Debt to Equity
86.22
Financial Highlights
Profitability
Gross Margin
72.92%
Operating Margin
-8.97%
Profit Margin
-21.33%
Returns and Earnings
Return on Assets (TTM)
-8.18%
Return on Equity (TTM)
-36.39%
EBITDA
$-22.2M
Net Income (TTM)
$-54.6M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$3.05
Quarterly Revenue Growth (YoY)
18.50%
Quarterly Earnings Growth (YoY)
18.47%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Paragon FNA | 1.10B Small-cap | 0.54% | 0.61% | 20.31% | 138.00% | 22.11% | 33.57% | -29.09% | -30.04% |
| Abbott Laboratories ABT | 234.39B Mega-cap | 0.78% | 1.82% | 0.11% | 2.25% | 18.64% | 19.49% | 32.22% | 22.75% |
| Boston Scientific BSX | 144.20B Large-cap | -0.88% | -9.50% | -6.71% | -1.20% | 8.88% | 15.12% | 144.77% | 136.56% |
| Novocure NVCR | 1.64B Small-cap | 13.73% | 21.36% | -17.22% | -13.66% | -51.12% | -0.41% | -81.98% | -89.43% |
| UFP Technologies UFPT | 1.53B Small-cap | 0.87% | -4.13% | -21.79% | 0.83% | -20.72% | -32.38% | 129.56% | 356.87% |
| Alphatec Holdings ATEC | 2.22B Mid-cap | -7.06% | -12.20% | 27.02% | 36.73% | 54.08% | 154.28% | 55.63% | 44.21% |
Ownership & Short Interest
Insider Ownership
31.22%
Institutional Ownership
50.84%
Shares Short
1M
Short Ratio
0.64
Short % of Shares Outstanding
2.13%
Average 10-Day Volume
5M
Average 90-Day Volume
2M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is FNA's 52-week high and low?
- In the last 52 weeks, Paragon reached a high of $13.13 (on January 29, 2025) and a low of $4.65 (on October 29, 2024).
- What is the market cap and P/E ratio for FNA?
- Curious about Paragon's size and valuation? Its market capitalization stands at 1.10B. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is -27.85.
- Does FNA pay dividends? If so, what's the yield?
- As for dividends, Paragon isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Paragon's main competitors or similar companies to consider before investing?
When looking at Paragon, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT234.39B Healthcare Medical Devices 19.49% 32.22% Boston Scientific
BSX144.20B Healthcare Medical Devices 15.12% 144.77% Novocure
NVCR1.64B Healthcare Medical Devices -0.41% -81.98% UFP Technologies
UFPT1.53B Healthcare Medical Devices -32.38% 129.56% Alphatec Holdings
ATEC2.22B Healthcare Medical Devices 154.28% 55.63% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Paragon 28 Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Paragon's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -36.39%, the Debt to Equity ratio from the most recent quarter is 86.22, and its Gross Profit Margin stands at 72.92%.
- What is the recent revenue and earnings growth for FNA?
- Looking at Paragon's growth, its revenue over the trailing twelve months (TTM) was $256M. Compared to the same quarter last year (YoY), quarterly revenue grew by 18.50%, and quarterly earnings saw a YoY growth of 18.47%.
- How much of FNA stock is held by insiders and institutions?
- Wondering who owns Paragon stock? Company insiders (like executives and directors) hold about 31.22% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 50.84%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.